ESC 365 - Professor Scott Solomon

Speaker illustration

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)

Member of:

Heart Failure Association

Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital. Dr. Solomon’s research interests have focused on changes in ventricular structure and function following myocardial infarction and in chronic heart failure, and heart failure with preserved ejection fraction, where he has led several phase 2 and phase 3 trials, including the first positive Phase II trial in HFpEF and the PARAGON-HF trial, which led to an expanded FDA indication for sacubitril/valsartan. His lab has pioneered the use of cardiac imaging in clinical trials. He has published over 800 peer reviewed articles, has served as Associate Editor at Circulation, European Heart Journal and European Journal of Heart Failure. He is an editor for the upcoming 12th edition of Braunwald's Heart Disease.

Sessions Presentations Articles

Ask the Trialists from Hot Line 2

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Ask the Trialists

Keynote lectures

Event: HFA Clinical Trials in Heart Failure Course 2022

Topic: Heart Failure

Session type: Symposium

Focus on selection criteria and outcomes

Event: HFA Clinical Trials in Heart Failure Course 2022

Topic: Heart Failure

Session type: Symposium

SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Event: ESC Congress 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Satellite Symposium

Late-Breaking Trials - Pharmacological treatment II

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Is HFpEF a disease of women? From biological to epidemiological evidence

Event: Heart Failure 2021

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Symposium

Learning from DAPA-HF one year on

Event: ESC Congress 2020

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Industry Q&A session

Heart failure with preserved ejection fraction

Event: ESC Congress 2019

Topic: Diagnostic Methods

Session type: Advances in Science

HFpEF - The new HFA consensus

Event: Heart Failure 2018

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Symposium

Novel drugs in heart failure

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session type: Symposium

ESC 365 is supported by